Oral Insulin Pills Could Transform Diabetes Care
For more than a century, scientists have searched for a way to deliver insulin in pill form. The challenge has always been the human digestive system, which breaks down insulin before it can reach the bloodstream. Now, researchers at Kumamoto University in Japan believe they may have found a solution.
Their breakthrough involves a cyclic peptide known as the DNP peptide, which helps insulin pass through the small intestine and enter the bloodstream without being destroyed. This innovation could finally make oral insulin a reality for millions of diabetes patients worldwide.
In laboratory tests, scientists experimented with two methods:
- Combining insulin with the peptide
- Chemically linking insulin and the peptide together
Both approaches produced encouraging results, successfully lowering blood sugar levels in diabetic mice.
One of the most significant achievements was the improved absorption rate, reaching between 33% and 41% bioavailability. This is a major leap compared to earlier attempts at oral insulin, which required much higher doses to achieve minimal effects.
The findings, published in Molecular Pharmaceutics, mark a critical step toward making insulin pills practical for everyday use. While the research is still in its early stages, scientists are now moving to larger models before beginning human trials.
If successful, insulin pills could revolutionize diabetes care by:
- Eliminating the need for daily injections
- Reducing treatment pain and discomfort
- Improving patient compliance and quality of life
This breakthrough offers hope to millions of people living with diabetes, signaling a future where managing the condition may become far less invasive and more accessible. As trials progress, the medical community eagerly awaits confirmation that insulin pills can safely and effectively replace injections in humans.
+ There are no comments
Add yours